Effect of glipizide on serum insulin and glucose concentrations in healthy cats

A. B. Miller, Richard W Nelson, C. A. Kirk, L. Neal, Edward C Feldman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

With the recent identification of non-insulin-dependent diabetes mellitus (NIDDM) in cats, new possibilities arise for the use of oral hypoglycaemic agents in the treatment of feline NIDDM, similar to their use in humans. To identify the future applicability of the oral hypoglycaemic agent, glipizide, in the treatment of feline NIDDM, its effects on serum insulin and glucose concentrations in healthy cats was examined. In addition, adverse effects seen clinically or on bloodwork following shortterm use of the drug were looked for. Serum insulin and glucose concentrations were evaluated after the oral administration of 2·5 5·0 and 10·0 mg glipizide and placebo in 10 healthy cats. For each drug trial, blood was obtained five minutes before, immediately before, and 7·5 15, 30, 45, 60, 90 and 120 minutes after glipizide or placebo administration. Mean serum insulin concentration increased after glipizide administration, with peak mean serum insulin concentration occurring 15 minutes after administration and declining to baseline by 60 minutes. There was no significant difference in peak mean serum insulin concentration, mean serum insulin concentration at 60 minutes after glipizide administration, or mean total insulin secretion between the three glipizide dosages. Mean serum glucose concentration decreased within 15 minutes of glipizide administration, with the glucose nadir occurring 60 minutes after glipizide administration. Placebo trials showed no significant change in mean serum insulin or glucose concentrations from baseline concentrations.

Original languageEnglish (US)
Pages (from-to)177-181
Number of pages5
JournalResearch in Veterinary Science
Volume52
Issue number2
DOIs
StatePublished - 1992

Fingerprint

glipizide
Glipizide
blood serum
Cats
insulin
cats
Insulin
Glucose
glucose
Serum
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
hypoglycemic agents
placebos
Felidae
Placebos
Hypoglycemic Agents
mouth
drugs
insulin secretion

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

Effect of glipizide on serum insulin and glucose concentrations in healthy cats. / Miller, A. B.; Nelson, Richard W; Kirk, C. A.; Neal, L.; Feldman, Edward C.

In: Research in Veterinary Science, Vol. 52, No. 2, 1992, p. 177-181.

Research output: Contribution to journalArticle

@article{769a21fdeacf40d08a3826a667d25d79,
title = "Effect of glipizide on serum insulin and glucose concentrations in healthy cats",
abstract = "With the recent identification of non-insulin-dependent diabetes mellitus (NIDDM) in cats, new possibilities arise for the use of oral hypoglycaemic agents in the treatment of feline NIDDM, similar to their use in humans. To identify the future applicability of the oral hypoglycaemic agent, glipizide, in the treatment of feline NIDDM, its effects on serum insulin and glucose concentrations in healthy cats was examined. In addition, adverse effects seen clinically or on bloodwork following shortterm use of the drug were looked for. Serum insulin and glucose concentrations were evaluated after the oral administration of 2·5 5·0 and 10·0 mg glipizide and placebo in 10 healthy cats. For each drug trial, blood was obtained five minutes before, immediately before, and 7·5 15, 30, 45, 60, 90 and 120 minutes after glipizide or placebo administration. Mean serum insulin concentration increased after glipizide administration, with peak mean serum insulin concentration occurring 15 minutes after administration and declining to baseline by 60 minutes. There was no significant difference in peak mean serum insulin concentration, mean serum insulin concentration at 60 minutes after glipizide administration, or mean total insulin secretion between the three glipizide dosages. Mean serum glucose concentration decreased within 15 minutes of glipizide administration, with the glucose nadir occurring 60 minutes after glipizide administration. Placebo trials showed no significant change in mean serum insulin or glucose concentrations from baseline concentrations.",
author = "Miller, {A. B.} and Nelson, {Richard W} and Kirk, {C. A.} and L. Neal and Feldman, {Edward C}",
year = "1992",
doi = "10.1016/0034-5288(92)90007-O",
language = "English (US)",
volume = "52",
pages = "177--181",
journal = "Research in Veterinary Science",
issn = "0034-5288",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Effect of glipizide on serum insulin and glucose concentrations in healthy cats

AU - Miller, A. B.

AU - Nelson, Richard W

AU - Kirk, C. A.

AU - Neal, L.

AU - Feldman, Edward C

PY - 1992

Y1 - 1992

N2 - With the recent identification of non-insulin-dependent diabetes mellitus (NIDDM) in cats, new possibilities arise for the use of oral hypoglycaemic agents in the treatment of feline NIDDM, similar to their use in humans. To identify the future applicability of the oral hypoglycaemic agent, glipizide, in the treatment of feline NIDDM, its effects on serum insulin and glucose concentrations in healthy cats was examined. In addition, adverse effects seen clinically or on bloodwork following shortterm use of the drug were looked for. Serum insulin and glucose concentrations were evaluated after the oral administration of 2·5 5·0 and 10·0 mg glipizide and placebo in 10 healthy cats. For each drug trial, blood was obtained five minutes before, immediately before, and 7·5 15, 30, 45, 60, 90 and 120 minutes after glipizide or placebo administration. Mean serum insulin concentration increased after glipizide administration, with peak mean serum insulin concentration occurring 15 minutes after administration and declining to baseline by 60 minutes. There was no significant difference in peak mean serum insulin concentration, mean serum insulin concentration at 60 minutes after glipizide administration, or mean total insulin secretion between the three glipizide dosages. Mean serum glucose concentration decreased within 15 minutes of glipizide administration, with the glucose nadir occurring 60 minutes after glipizide administration. Placebo trials showed no significant change in mean serum insulin or glucose concentrations from baseline concentrations.

AB - With the recent identification of non-insulin-dependent diabetes mellitus (NIDDM) in cats, new possibilities arise for the use of oral hypoglycaemic agents in the treatment of feline NIDDM, similar to their use in humans. To identify the future applicability of the oral hypoglycaemic agent, glipizide, in the treatment of feline NIDDM, its effects on serum insulin and glucose concentrations in healthy cats was examined. In addition, adverse effects seen clinically or on bloodwork following shortterm use of the drug were looked for. Serum insulin and glucose concentrations were evaluated after the oral administration of 2·5 5·0 and 10·0 mg glipizide and placebo in 10 healthy cats. For each drug trial, blood was obtained five minutes before, immediately before, and 7·5 15, 30, 45, 60, 90 and 120 minutes after glipizide or placebo administration. Mean serum insulin concentration increased after glipizide administration, with peak mean serum insulin concentration occurring 15 minutes after administration and declining to baseline by 60 minutes. There was no significant difference in peak mean serum insulin concentration, mean serum insulin concentration at 60 minutes after glipizide administration, or mean total insulin secretion between the three glipizide dosages. Mean serum glucose concentration decreased within 15 minutes of glipizide administration, with the glucose nadir occurring 60 minutes after glipizide administration. Placebo trials showed no significant change in mean serum insulin or glucose concentrations from baseline concentrations.

UR - http://www.scopus.com/inward/record.url?scp=0026566599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026566599&partnerID=8YFLogxK

U2 - 10.1016/0034-5288(92)90007-O

DO - 10.1016/0034-5288(92)90007-O

M3 - Article

C2 - 1585076

AN - SCOPUS:0026566599

VL - 52

SP - 177

EP - 181

JO - Research in Veterinary Science

JF - Research in Veterinary Science

SN - 0034-5288

IS - 2

ER -